Literature DB >> 23701040

Negotiating access to medical treatment and the making of patient citizenship: the case of hepatitis C treatment.

Tim Rhodes1, Magdalena Harris, Anthea Martin.   

Abstract

Drawing on qualitative interview accounts with people who have injected drugs, we deploy ideas of biological and therapeutic citizenship to explore how the negotiation of access to hepatitis C treatment enacts patient citizenship potential. We find that the patient citizenship made through hepatitis C treatment divides those who are deserving from those who are not, largely in relation to their presentations of self-control, responsibility and recovery regarding drug use. Accessing treatment requires that patients negotiate their entitlement by reflexively producing the patient citizen role expected of them. In this context of rationed treatment expectation, access to treatment is constructed in relation to gratitude rather than entitlement. Rationed treatment expectation also interplays with a utilitarian approach to hepatitis C expertise. Accounts of the bio-effects of hepatitis C and its treatment as uncertain further weaken the potential for shared illness identity and biosocial membership as well as contributing to treatment delay. We conclude that the construction of hepatitis C treatment as a negotiation of 'recovery towards normality' positions people who continue to use or inject drugs as beyond patient citizenship. Our findings underscore the situated limits of therapeutic and biological citizenship, emphasising that these processes are unavoidably forces of governance.
© 2013 The Authors. Sociology of Health & Illness © 2013 Foundation for the Sociology of Health & Illness/John Wiley & Sons Ltd. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  biological citizenship; expert patient; hepatitis C; injecting drug use; therapeutic citizenship

Mesh:

Year:  2013        PMID: 23701040     DOI: 10.1111/1467-9566.12018

Source DB:  PubMed          Journal:  Sociol Health Illn        ISSN: 0141-9889


  13 in total

1.  The Second Canadian Symposium on hepatitis C virus: a call to action.

Authors:  Jason Grebely; Marc Bilodeau; Jordan J Feld; Julie Bruneau; Benedikt Fischer; Jennifer F Raven; Eve Roberts; Norma Choucha; Rob P Myers; Selena M Sagan; Joyce A Wilson; Frank Bialystok; D Lorne Tyrrell; Michael Houghton; Mel Krajden
Journal:  Can J Gastroenterol       Date:  2013-11       Impact factor: 3.522

2.  The becoming of methadone in Kenya: How an intervention's implementation constitutes recovery potential.

Authors:  Tim Rhodes
Journal:  Soc Sci Med       Date:  2018-02-10       Impact factor: 4.634

3.  Is the promise of methadone Kenya's solution to managing HIV and addiction? A mixed-method mathematical modelling and qualitative study.

Authors:  Tim Rhodes; Andy Guise; James Ndimbii; Steffanie Strathdee; Elizabeth Ngugi; Lucy Platt; Ann Kurth; Charles Cleland; Peter Vickerman
Journal:  BMJ Open       Date:  2015-03-06       Impact factor: 2.692

4.  Using peer advocates to improve access to services among hard-to-reach populations with hepatitis C: a qualitative study of client and provider relationships.

Authors:  Jennifer MacLellan; Julian Surey; Ibrahim Abubakar; Helen R Stagg; Jenevieve Mannell
Journal:  Harm Reduct J       Date:  2017-11-28

5.  Beyond interferon side effects: What residual barriers exist to DAA hepatitis C treatment for people who inject drugs?

Authors:  Annie Madden; Max Hopwood; Joanne Neale; Carla Treloar
Journal:  PLoS One       Date:  2018-11-30       Impact factor: 3.240

6.  Hepatitis C virus screening and treatment in Irish prisons from nurse managers' perspectives - a qualitative exploration.

Authors:  D Crowley; M C Van Hout; C Murphy; E Kelly; J S Lambert; W Cullen
Journal:  BMC Nurs       Date:  2019-06-13

7.  Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) - a natural experiment (protocol).

Authors:  Matthew Hickman; John F Dillon; Lawrie Elliott; Daniela De Angelis; Peter Vickerman; Graham Foster; Peter Donnan; Ann Eriksen; Paul Flowers; David Goldberg; William Hollingworth; Samreen Ijaz; David Liddell; Sema Mandal; Natasha Martin; Lewis J Z Beer; Kate Drysdale; Hannah Fraser; Rachel Glass; Lesley Graham; Rory N Gunson; Emma Hamilton; Helen Harris; Magdalena Harris; Ross Harris; Ellen Heinsbroek; Vivian Hope; Jeremy Horwood; Sarah Karen Inglis; Hamish Innes; Athene Lane; Jade Meadows; Andrew McAuley; Chris Metcalfe; Stephanie Migchelsen; Alex Murray; Gareth Myring; Norah E Palmateer; Anne Presanis; Andrew Radley; Mary Ramsay; Pantelis Samartsidis; Ruth Simmons; Katy Sinka; Gabriele Vojt; Zoe Ward; David Whiteley; Alan Yeung; Sharon J Hutchinson
Journal:  BMJ Open       Date:  2019-09-24       Impact factor: 2.692

8.  Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners.

Authors:  Desmond Crowley; Ross Murtagh; Walter Cullen; Mary Keevans; Eamon Laird; Tina McHugh; Susan McKiernan; Sarah Jayne Miggin; Eileen O'Connor; Deirdre O'Reilly; Graham Betts-Symonds; Ciara Tobin; Marie Claire Van Hout; John S Lambert
Journal:  Harm Reduct J       Date:  2019-07-05

9.  Exploring and understanding HCV patient journeys- HEPCARE Europe project.

Authors:  Shannon Glaspy; Gordana Avramovic; Tina McHugh; Cristiana Oprea; Julian Surey; Irina Ianache; Juan Macías; Alistair Story; Walter Cullen; John S Lambert
Journal:  BMC Infect Dis       Date:  2021-03-05       Impact factor: 3.090

10.  "I want to get better, but…": identifying the perceptions and experiences of people who inject drugs with respect to evolving hepatitis C virus treatments.

Authors:  Trevor Goodyear; Helen Brown; Annette J Browne; Peter Hoong; Lianping Ti; Rod Knight
Journal:  Int J Equity Health       Date:  2021-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.